NEW YORK, May 3, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:
Advanced Disposal Services, Inc. (NYSE: ADSW) ("Advanced Disposal Services") regarding the sale of Advanced Disposal Services to Waste Management, Inc. Under the terms of the proposed transaction, Advanced Disposal Services stockholders will receive $33.15 for each Advanced Disposal Services share they own.
Click here for more information: https://www.monteverdelaw.com/case/advanced-disposal-services-inc. It is free and there is no cost or obligation to you.
AmeriGas Partners, L.P. (NYSE: APU) ("AmeriGas") regarding the sale of AmeriGas to UGI Corporation ("UGI"), where AmeriGas shareholders will receive one of the following forms of merger consideration: (i) 0.6378 shares of UGI common stock; (ii) $7.63 in cash and 0.500 UGI Shares; or (iii) $35.325 in cash for each AmeriGas share they own.
Click here for more information: https://www.monteverdelaw.com/case/amerigas-partners-lp. It is free and there is no cost or obligation to you.
Anadarko Petroleum Corporation (NYSE: APC) ("Anadarko Petroleum") regarding the sale of Anadarko Petroleum to the Chevron Corporation ("Chevron"). Under the terms of the proposed transaction, Anadarko Petroleum stockholders will receive $16.25 in cash, and 0.3869 of a share of common stock of Chevron, plus cash in lieu of any fractional Chevron shares that otherwise would have been issued for each Anadarko Petroleum share they own.
Click here for more information: https://www.monteverdelaw.com/case/anadarko-petroleum-corporation. It is free and there is no cost or obligation to you.
Aratana Therapeutics, Inc. (NASDAQ GM: PETX) ("Aratana Therapeutics") regarding the sale of Aratana Therapeutics to Elanco Athens Inc. ("Elanco"). Under the terms of the proposed transaction, Aratana Therapeutics stockholders will receive 0.1481 shares of Elanco common stock plus one contingent value right ("CVR") representing the right to receive $0.25 in cash if a specified milestone is achieved, as set forth in the CVR Agreement, for each Aratana Therapeutics share they own.
Click here for more information: https://www.monteverdelaw.com/case/aratana-therapeutics-inc. It is free and there is no cost or obligation to you.
Electronics For Imaging, Inc. (NASDAQ GS: EFII) ("EFI") regarding the sale of EFI to East Private Holdings II, LLC, an affiliate of Siris Capital Group. Under the terms of the proposed transaction, EFI stockholders will receive right to receive $37.00 in cash for each EFI share they own.
Click here for more information: https://www.monteverdelaw.com/case/electronics-imaging-inc. It is free and there is no cost or obligation to you.
Gardner Denver Holdings, Inc. (NYSE: GDI) ("Gardner Denver") regarding the company's merger with Ingersoll-Rand PLC. Under the terms of the proposed transaction, Ingersoll Rand shareholders are to own 50.1% of the combined company, with existing stockholders of Gardner Denver owning 49.9% of the combined company.
Click here for more information: https://www.monteverdelaw.com/case/gardner-denver-holdings-inc. It is free and there is no cost or obligation to you.
Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017 - 2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (212) 971-1341.
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
Tel: (212) 971-1341
Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE Monteverde & Associates PC